Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluate the Immunogenicity and Safety of Rabies Vaccine Given in a Post-exposure Prophylaxis Regimen to Healthy Children and Adults Aged 10-60 Years.

NCT00345319 is registered in ClinicalTrials.gov with Novartis Vaccines as lead sponsor.

NCT NCT00345319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00345319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluate the Immunogenicity and Safety of Rabies Vaccine Given in a Post-exposure Prophylaxis Regimen to Healthy Children and Adults Aged 10-60 Years.
Lead sponsor
Novartis Vaccines
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2006
Completion date
May 31, 2006
Enrollment
630 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rabies post-exposure prophylaxis